Merck & Co (NYSE: MRK)

DRUGS - Drug Manufacturers - Major

Health Care

Stock price data as of

Closing price: $110.53
  • Support level
    $98.17
  • Resistance level
    N/A
  • Beta
    0.3
  • RSI (14-day)
    84.3
  • MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • MRK is one of this month's top performers with a return of 13.2 percent, beating 90 percent of stocks in the S&P-100.
  • Volatility is forecast to fall over the next month.
  • With RSI > 70, MRK is overbought. Odds slightly favor a short-term price reversal.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range

52-week low 52-week high Price as % of range
$73.47 $110.99 99.0%

Moving averages

200 day 50 day 20 day 10 day
$86.07 $98.42 $104.63 $107.76

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    7.2%
  • In the next month
    13.1%
  • In the next year
    57.6%

Volatility estimates (annualized standard deviations)

Period Value
Historical (5 year) 23.0%
Last month 22.5%
Current estimate 26.3%
Next month forecast 23.1%